Medikaloka Hermina Pt Stock Price To Book
| HEAL Stock | IDR 1,290 10.00 0.77% |
Medikaloka Hermina PT fundamentals help investors to digest information that contributes to Medikaloka Hermina's financial success or failures. It also enables traders to predict the movement of Medikaloka Stock. The fundamental analysis module provides a way to measure Medikaloka Hermina's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Medikaloka Hermina stock.
Medikaloka |
Medikaloka Hermina PT Company Price To Book Analysis
Medikaloka Hermina's Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Current Medikaloka Hermina Price To Book | 6.72 X |
Most of Medikaloka Hermina's fundamental indicators, such as Price To Book, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Medikaloka Hermina PT is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
| Competition |
Based on the latest financial disclosure, Medikaloka Hermina PT has a Price To Book of 6.7217 times. This is 73.83% lower than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The price to book for all Indonesia stocks is 29.32% higher than that of the company.
Medikaloka Price To Book Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Medikaloka Hermina's direct or indirect competition against its Price To Book to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Medikaloka Hermina could also be used in its relative valuation, which is a method of valuing Medikaloka Hermina by comparing valuation metrics of similar companies.Medikaloka Hermina is currently under evaluation in price to book category among related companies.
Medikaloka Fundamentals
| Return On Equity | 0.14 | |||
| Return On Asset | 0.0704 | |||
| Profit Margin | 0.1 % | |||
| Operating Margin | 0.18 % | |||
| Current Valuation | 23.44 T | |||
| Shares Outstanding | 14.48 B | |||
| Shares Owned By Insiders | 51.07 % | |||
| Shares Owned By Institutions | 7.10 % | |||
| Price To Earning | 7.42 X | |||
| Price To Book | 6.72 X | |||
| Price To Sales | 4.66 X | |||
| Revenue | 5.82 T | |||
| Gross Profit | 2.71 T | |||
| EBITDA | 1.9 T | |||
| Net Income | 1 T | |||
| Cash And Equivalents | 590.19 B | |||
| Cash Per Share | 40.20 X | |||
| Total Debt | 1.47 T | |||
| Debt To Equity | 0.41 % | |||
| Current Ratio | 1.59 X | |||
| Book Value Per Share | 230.87 X | |||
| Cash Flow From Operations | 1.86 T | |||
| Earnings Per Share | 32.62 X | |||
| Target Price | 1693.1 | |||
| Number Of Employees | 14.38 K | |||
| Beta | 0.4 | |||
| Market Capitalization | 22.15 T | |||
| Total Asset | 7.59 T | |||
| Z Score | 9.0 | |||
| Annual Yield | 0 % | |||
| Net Asset | 7.59 T | |||
| Last Dividend Paid | 6.0 |
About Medikaloka Hermina Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Medikaloka Hermina PT's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Medikaloka Hermina using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Medikaloka Hermina PT based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Medikaloka Hermina using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Medikaloka Hermina PT. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Complementary Tools for Medikaloka Stock analysis
When running Medikaloka Hermina's price analysis, check to measure Medikaloka Hermina's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medikaloka Hermina is operating at the current time. Most of Medikaloka Hermina's value examination focuses on studying past and present price action to predict the probability of Medikaloka Hermina's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medikaloka Hermina's price. Additionally, you may evaluate how the addition of Medikaloka Hermina to your portfolios can decrease your overall portfolio volatility.
| Stocks Directory Find actively traded stocks across global markets | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |